Profile
Rupert Haynes is currently the Head-Global Strategy at Radius Health, Inc. He was previously the Chief Executive Officer at FSD Pharma, Inc. from 2018 to 2019.
Prior to that, he held positions as Director-Global Marketing at GW Pharmaceuticals Ltd.
and Head-Global Commercial Operations at Swedish Orphan Biovitrum AB.
Rupert Haynes active positions
Companies | Position | Start |
---|---|---|
RADIUS HEALTH, INC. | Corporate Officer/Principal | 2021-01-31 |
Former positions of Rupert Haynes
Companies | Position | End |
---|---|---|
FSD PHARMA INC. | Chief Executive Officer | 2019-02-05 |
GW PHARMACEUTICALS PLC | Sales & Marketing | - |
SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
FSD PHARMA INC. | Health Technology |
Private companies | 2 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Rupert Haynes